Nektar Therapeutics · NASDAQ:NKTR
Whitfield Roy A received 2,000 Nektar Therapeutics shares as an award (Form 4)
Traded Sep 23, 2026 · Filed Sep 25, 2026
On Sep 23, 2026, Whitfield Roy A (Director) received 2,000 Nektar Therapeutics shares as an award, leaving 16,417 shares. Filed Sep 25, 2026 (Form 4).
- Awarded
- 2,000 shares
- Holding after
- 16,417 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Common Stock | Award | 2,000 | 16,417 | Direct |